Logo image of ALMER.PA

SAPMER (ALMER.PA) Stock Fundamental Analysis

EPA:ALMER - Euronext Paris - Matif - FR0010776617 - Common Stock - Currency: EUR

6.9  -0.25 (-3.5%)

Fundamental Rating

2

ALMER gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 60 industry peers in the Food Products industry. Both the profitability and financial health of ALMER have multiple concerns. ALMER is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALMER had positive earnings in the past year.
In the past year ALMER had a positive cash flow from operations.
ALMER had negative earnings in 4 of the past 5 years.
In multiple years ALMER reported negative operating cash flow during the last 5 years.
ALMER.PA Yearly Net Income VS EBIT VS OCF VS FCFALMER.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

1.2 Ratios

ALMER has a Return On Assets of -28.23%. This is amonst the worse of the industry: ALMER underperforms 90.00% of its industry peers.
With a Return On Equity value of -105.17%, ALMER is not doing good in the industry: 90.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -28.23%
ROE -105.17%
ROIC N/A
ROA(3y)-6.31%
ROA(5y)-6.54%
ROE(3y)-40.92%
ROE(5y)-36.91%
ROIC(3y)N/A
ROIC(5y)N/A
ALMER.PA Yearly ROA, ROE, ROICALMER.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

ALMER's Gross Margin of 64.52% is amongst the best of the industry. ALMER outperforms 93.33% of its industry peers.
ALMER's Gross Margin has been stable in the last couple of years.
ALMER does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.11%
GM growth 5Y0.37%
ALMER.PA Yearly Profit, Operating, Gross MarginsALMER.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

ALMER does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALMER has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ALMER has been increased compared to 5 years ago.
Compared to 1 year ago, ALMER has a worse debt to assets ratio.
ALMER.PA Yearly Shares OutstandingALMER.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
ALMER.PA Yearly Total Debt VS Total AssetsALMER.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of 0.74, we must say that ALMER is in the distress zone and has some risk of bankruptcy.
ALMER has a Altman-Z score of 0.74. This is amonst the worse of the industry: ALMER underperforms 83.33% of its industry peers.
ALMER has a debt to FCF ratio of 17.39. This is a negative value and a sign of low solvency as ALMER would need 17.39 years to pay back of all of its debts.
ALMER has a worse Debt to FCF ratio (17.39) than 65.00% of its industry peers.
ALMER has a Debt/Equity ratio of 1.29. This is a high value indicating a heavy dependency on external financing.
ALMER has a worse Debt to Equity ratio (1.29) than 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF 17.39
Altman-Z 0.74
ROIC/WACCN/A
WACC6.9%
ALMER.PA Yearly LT Debt VS Equity VS FCFALMER.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

ALMER has a Current Ratio of 1.57. This is a normal value and indicates that ALMER is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.57, ALMER is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
ALMER has a Quick Ratio of 1.07. This is a normal value and indicates that ALMER is financially healthy and should not expect problems in meeting its short term obligations.
ALMER has a better Quick ratio (1.07) than 65.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 1.07
ALMER.PA Yearly Current Assets VS Current LiabilitesALMER.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 100.09% over the past year.
Looking at the last year, ALMER shows a very negative growth in Revenue. The Revenue has decreased by -27.44% in the last year.
ALMER shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -9.08% yearly.
EPS 1Y (TTM)100.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%108.95%
Revenue 1Y (TTM)-27.44%
Revenue growth 3Y-11.39%
Revenue growth 5Y-9.08%
Sales Q2Q%-17.25%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALMER.PA Yearly Revenue VS EstimatesALMER.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 690.00, ALMER can be considered very expensive at the moment.
ALMER's Price/Earnings ratio is a bit more expensive when compared to the industry. ALMER is more expensive than 70.00% of the companies in the same industry.
ALMER's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.48.
Industry RankSector Rank
PE 690
Fwd PE N/A
ALMER.PA Price Earnings VS Forward Price EarningsALMER.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALMER is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 16.08
EV/EBITDA N/A
ALMER.PA Per share dataALMER.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALMER does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SAPMER

EPA:ALMER (8/4/2025, 7:00:00 PM)

6.9

-0.25 (-3.5%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap42.09M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 690
Fwd PE N/A
P/S 0.37
P/FCF 16.08
P/OCF 5.51
P/B 1.23
P/tB 1.25
EV/EBITDA N/A
EPS(TTM)0.01
EY0.14%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.43
FCFY6.22%
OCF(TTM)1.25
OCFY18.14%
SpS18.61
BVpS5.59
TBVpS5.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -28.23%
ROE -105.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.52%
FCFM 2.3%
ROA(3y)-6.31%
ROA(5y)-6.54%
ROE(3y)-40.92%
ROE(5y)-36.91%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.11%
GM growth 5Y0.37%
F-Score3
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF 17.39
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 4.42%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.57
Quick Ratio 1.07
Altman-Z 0.74
F-Score3
WACC6.9%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)6.07%
Cap/Sales(5y)6.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%108.95%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-27.44%
Revenue growth 3Y-11.39%
Revenue growth 5Y-9.08%
Sales Q2Q%-17.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-690.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-69.48%
OCF growth 3YN/A
OCF growth 5YN/A